GA
General Atlantic Portfolio holdings
AUM
$3.63B
1-Year Est. Return
68.62%
1 Year Est. Return
+68.62%
AUM
$2.98B
AUM Growth
+$170M
(+6%)
Holding
16
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 57.12% |
| 2 | Technology | 27.22% |
| 3 | Financials | 13.67% |
| 4 | Consumer Staples | 1.85% |
| 5 | Consumer Discretionary | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alignment Healthcare
ALHC
$3.36B
| $1.14B | 38.12% |
60,993,323
|
|
||
2
dLocal
DLO
$4.52B
| $533M | 17.89% |
63,906,695
|
|
||
3
XP
XP
$8.64B
| $407M | 13.67% |
29,617,733
|
|
||
4
Alkami Technology
ALKT
$2.33B
| $253M | 8.5% |
9,645,318
|
|
||
5
Akero Therapeutics
AKRO
$4.3B
| $212M | 7.11% |
5,233,989
|
|
||
|
CNTA
6
Centessa Pharmaceuticals
CNTA
$3.06B
| $139M | 4.67% |
9,681,818
|
|
||
7
Pharvaris
PHVS
$1.41B
| $118M | 3.97% |
7,531,252
|
|
||
8
European Wax Center
EWCZ
$150M
| $51.8M | 1.74% |
13,110,492
|
|
||
9
Royalty Pharma
RPRX
$15.7B
| $46.7M | 1.57% |
1,500,000
|
|
||
10
Immunocore
IMCR
$1.69B
| $37.4M | 1.26% |
1,261,684
|
|
||
11
Riskified
RSKD
$729M
| $24.6M | 0.83% |
5,324,998
|
|
||
|
SLRN
12
DELISTED
ACELYRIN
SLRN
| $6.66M | 0.22% |
2,695,327
|
|
||
|
ADAG
13
Adagene
ADAG
$83.9M
| $5.82M | 0.2% |
3,825,952
|
|
||
|
LOGC
14
DELISTED
ContextLogic
LOGC
| $4.26M | 0.14% |
609,616
|
|
||
15
Grove Collaborative
GROV
$63.2M
| $3.34M | 0.11% |
2,474,859
|
|
||
|
THRD
16
DELISTED
Third Harmonic Bio
THRD
| – | – |
-3,372,323
|
|